Leflunomide in Systemic Lupus Erythematosus
NCT00637819
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
27
Enrollment
INDUSTRY
Sponsor class
Conditions
Systemic Lupus Eythematosus (SLE)
Interventions
DRUG:
Leflunomide
Sponsor
Sanofi